United Kingdom· GB-APID-35820211000001100
Rubraca 300mg tablets
A rucaparib product containing rucaparib, registered in United Kingdom by pharmaand GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Rucaparib is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XK03 (rucaparib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Rucaparib · ATC L01XK03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of rucaparib costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rucaparib · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$240.27
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Rucaparib
- Manufacturer
- pharmaand GmbH
- Country
- United Kingdom (GB)
- ATC code
- L01XK03
- ATC class
- Rucaparib
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin03696609000380
- gtin09120099676083
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
692 interactions on record for rucaparib.
Graded by severity as the source publishes them — 103 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rucaparib · interactions on record
692 records
- 103 severe
- 576 moderate
- 13 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LonafarnibA16AX20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rucaparib in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandRubraca 200 mg, Filmtablettenmmpharm GmbH
- SpainRUBRACA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPharmaand Gmbh
- NetherlandsRubraca 200 mg, filmomhulde tablettenzr pharma& GmbH
- SwedenRubraca 200 mg Filmdragerad tablettpharmaand GmbH
- NorwayRubracapharmaand GmbH
- PolandRubracapharmaand GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rubraca
- Liechtenstein · Rubraca
- Norway · Rubraca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a857e35a-dd46-41c4-9adf-93807aeffe7c GET /v1/drugs/a857e35a-dd46-41c4-9adf-93807aeffe7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "35820211000001100",
"desc": "Rubraca 300mg tablets (pharmaand GmbH)",
"form": "Oral tablet",
"vpid": "35820011000001105",
"source": "dmd",
"vtm_id": "777474000",
"strength": "300 mg",
"substance": "Rucaparib",
"ingredient": "Rucaparib camsilate",
"supplier_code": "41622111000001102"
}See everything about rucaparib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.